Financhill
Buy
61

STXE Quote, Financials, Valuation and Earnings

Last price:
$27.97
Seasonality move :
8.25%
Day range:
$27.88 - $28.15
52-week range:
$24.75 - $31.90
Dividend yield:
3.62%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
7.7K
Avg. volume:
16.9K
1-year change:
-0.23%
Market cap:
--
Revenue:
--
EPS (TTM):
--

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Strive Emerging Markets Ex-China ETF has -- downside to fair value with a price target of -- per share.

STXE vs. S&P 500

  • Over the past 5 trading days, Strive Emerging Markets Ex-China ETF has overperformed the S&P 500 by 1.46% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Strive Emerging Markets Ex-China ETF does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Strive Emerging Markets Ex-China ETF has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Strive Emerging Markets Ex-China ETF reported revenues of --.

Earnings Growth

  • Strive Emerging Markets Ex-China ETF has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Strive Emerging Markets Ex-China ETF reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2023-05-02 2024-05-02 2024-05-02
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -- -- -- -- --
EBITDA -- -- -- -- --
Diluted EPS -- -- -- -- --
Period Ending 2021-05-02 2022-05-02 2023-05-02 2024-05-02
Balance Sheet
Current Assets -- -- -- -- --
Total Assets -- -- -- -- --
Current Liabilities -- -- -- -- --
Total Liabilities -- -- -- -- --
Total Equity -- -- -- -- --
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2023-05-02 2024-05-02 2024-05-02
Cash Flow Statement
Cash Flow Operations -- -- -- -- --
Cash From Investing -- -- -- -- --
Cash From Financing -- -- -- -- --
Free Cash Flow -- -- -- -- --
STXE
Sector
Market Cap
--
--
Price % of 52-Week High
88.26%
--
Dividend Yield
3.62%
--
Shareholder Yield
--
--
1-Year Price Total Return
-0.23%
--
Beta (5-Year)
--
--
Dividend yield:
3.62%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $27.68
200-day SMA
Sell
Level $28.86
Bollinger Bands (100)
Buy
Level 26.99 - 28.53
Chaikin Money Flow
Buy
Level 3.4M
20-day SMA
Buy
Level $26.94
Relative Strength Index (RSI14)
Buy
Level 61.63
ADX Line
Buy
Level 13.61
Williams %R
Sell
Level 0
50-day SMA
Buy
Level $27.34
MACD (12, 26)
Buy
Level 0.21
25-day Aroon Oscillator
Buy
Level 64
On Balance Volume
Neutral
Level 675.1K

Financial Scores

--
Altman Z-Score (Annual)
Level (--)
--
CA Score (Annual)
Level (--)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (5)
--
Ohlson Score
Level (--)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Stock Forecast FAQ

In the current month, STXE has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The STXE average analyst price target in the past 3 months is --.

  • Where Will Strive Emerging Markets Ex-China ETF Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Strive Emerging Markets Ex-China ETF share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Strive Emerging Markets Ex-China ETF?

    Analysts are divided on their view about Strive Emerging Markets Ex-China ETF share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Strive Emerging Markets Ex-China ETF is a Sell and believe this share price will rise from its current level to --.

  • What Is Strive Emerging Markets Ex-China ETF's Price Target?

    The price target for Strive Emerging Markets Ex-China ETF over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is STXE A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Strive Emerging Markets Ex-China ETF is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of STXE?

    You can purchase shares of Strive Emerging Markets Ex-China ETF via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Strive Emerging Markets Ex-China ETF shares.

  • What Is The Strive Emerging Markets Ex-China ETF Share Price Today?

    Strive Emerging Markets Ex-China ETF was last trading at $27.97 per share. This represents the most recent stock quote for Strive Emerging Markets Ex-China ETF. Yesterday, Strive Emerging Markets Ex-China ETF closed at $28.15 per share.

  • How To Buy Strive Emerging Markets Ex-China ETF Stock Online?

    In order to purchase Strive Emerging Markets Ex-China ETF stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Palantir Stock a Millionaire Maker?
Is Palantir Stock a Millionaire Maker?

Palantir (NASDAQ:PLTR) has shot upward over the last year and…

Is QuantumScape a Buy Now?
Is QuantumScape a Buy Now?

QuantumScape (NYSE:QS) is an innovative EV battery company that specializes…

Is Vertex Stock Still a Good Buy?
Is Vertex Stock Still a Good Buy?

Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…

Stock Ideas

Buy
61
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Sell
50
RGC alert for May 1

Regencell Bioscience Holdings [RGC] is up 20.58% over the past day.

Sell
38
WGS alert for May 1

GeneDx Holdings [WGS] is down 6.85% over the past day.

Sell
43
VICR alert for May 1

Vicor [VICR] is down 1.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock